Loading...
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
BACKGROUND: Claudication secondary to peripheral artery disease (PAD) is associated with substantial functional impairment. Phosphodiesterase (PDE) inhibitors have been shown to increase walking performance in these patients. K-134 is a selective PDE 3 inhibitor being developed as a potential treatm...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126735/ https://ncbi.nlm.nih.gov/pubmed/21612611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-134 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|